AnaptysBio
ANAB
ANAB
52 hedge funds and large institutions have $328M invested in AnaptysBio in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.52% less ownership
Funds ownership: 68.13% → 67.61% (-0.52%)
14% less capital invested
Capital invested by funds: $382M → $328M (-$53.6M)
Holders
52
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$6.86M | |
| 2 | +$4.91M | |
| 3 | +$1.68M | |
| 4 |
BlackRock
New York
|
+$1.29M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.12M |
Top Sellers
| 1 | -$7.01M | |
| 2 | -$2.79M | |
| 3 | -$2.42M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.3M |
| 5 |
JPMorgan Chase & Co
New York
|
-$1.91M |